Atrial Fibrillation and Cognitive Impairment

Growing evidence suggests that atrial fibrillation (AF), in addition to its known thromboembolic risk, is a risk factor for significant cognitive impairment via several pathways, further contributing to morbidity and mortality. Whether anticoagulation, rhythm control strategies and other interventions aiming at preventing thromboembolic events and ameliorating the clinical outcome of AF patients, may also have a beneficial effect on long-term cognitive function remains to be seen in future studies